dengu
viru
type
predomin
serotyp
caus
major
dengu
epidem
number
studi
carri
find
effect
antivir
howev
date
still
molecul
either
peptid
small
molecul
releas
drug
present
studi
aim
identifi
small
molecul
inhibitor
nation
cancer
institut
databas
virtual
screen
one
hit
ic
bear
thioguanin
scaffold
derivatis
compound
evalu
proteas
inhibitori
activ
compound
demonstr
potent
activ
ic
respect
molecular
dynam
mmpbsa
free
energi
bind
calcul
conduct
studi
interact
mechan
compound
proteas
free
energi
bind
calcul
mmpbsa
kcalmol
compar
known
inhibitor
panduratin
kcalmol
corrobor
well
experiment
observ
result
molecular
dynam
simul
also
show
bind
activ
site
stabilis
format
hydrogen
bond
dengu
caus
dengu
viru
denv
import
mosquitoborn
viral
diseas
affect
tropic
subtrop
endem
countri
viru
estim
caus
million
infect
year
denv
infect
result
seriou
diseas
includ
dengu
fever
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
even
death
approv
antivir
drug
diseas
current
patient
treat
support
care
reliev
fever
pain
dehydr
tetraval
dengu
vaccin
cydtdenv
dengvaxia
first
dengu
vaccin
recent
regist
sever
countri
despit
lead
caus
hospitalis
death
among
children
asian
latin
american
countri
vaccin
recommend
use
children
year
age
due
safeti
concern
therefor
exist
urgent
need
antivir
therapi
treat
dengu
denv
carri
posit
singl
strand
rna
genom
five
serotyp
identifi
preval
type
dengu
epidem
especi
south
east
asian
region
associ
sever
dengu
case
new
serotyp
discov
sarawak
malaysia
complic
prevent
treatment
diseas
viru
genom
encod
three
structur
protein
c
prm
e
well
seven
nonstructur
protein
protein
well
studi
regard
promis
target
antidengu
discoveri
trypsin
like
serin
proteas
play
role
posttransl
viru
matur
domain
catalyt
triad
made
activ
enhanc
cofactor
cofactor
contribut
activ
hydrophil
region
respons
hold
promot
activ
hydrophob
region
take
part
membran
associ
upon
cleavag
process
previou
discoveri
dengu
inhibitor
target
activ
mainli
base
nonprim
substrat
identifi
profil
dengu
viru
use
tetrapeptid
signific
challeng
aris
protein
possess
solventexpos
topolog
shallow
activ
site
depend
select
substrat
contain
basic
amino
acid
arginin
lysin
posit
nevertheless
mani
peptid
modifi
peptid
molecul
discov
good
inhibit
activ
addit
also
report
potent
small
molecul
inhibitor
natur
product
panduratin
agathisflavon
quercetin
synthet
medicin
chemistri
dehydronaphthalen
benzimidazol
thiadiazoloacrylamid
utilis
comput
method
report
discoveri
potenti
inhibitor
design
base
thioguanin
scaffold
identifi
virtual
screen
compound
librari
nation
cancer
institut
nci
divers
set
ii
twentyfour
compound
found
silico
hit
base
free
energi
bind
bind
rank
total
compound
twenti
obtain
nci
vitro
assay
four
demonstr
moder
inhibit
toward
ic
although
potent
compound
identifi
virtual
screen
structur
contain
thioguanin
tg
scaffold
use
templat
develop
seri
analogu
simpl
chemic
structur
benefit
feasibl
synthet
step
tg
show
inhibit
mm
indic
even
without
modif
structur
scaffold
abl
inhibit
proteas
activ
compound
drug
class
antineoplast
agent
use
compound
treat
leukemia
investig
mani
pharmacolog
activ
immunomodul
autoimmun
diseas
transplant
graft
reject
initi
studi
interest
utilis
thioguanin
scaffold
design
inhibitor
thu
studi
design
synthesis
thioguanin
analogu
investig
possibl
inhibit
activ
hope
studi
could
contribut
effort
discov
novel
potent
antidengu
agent
virtual
screen
carri
use
autodockvina
wwwautodockscrippsedu
model
taken
publish
articl
model
built
base
complex
cofactorproteas
use
crystal
structur
west
nile
viru
wnv
templat
dock
procedur
initi
prepar
macromolecul
use
autodock
tool
version
default
paramet
dock
autodock
vina
exhaust
set
paramet
unchang
centr
grid
box
set
x
z
coordin
respect
box
size
x
x
point
intern
valid
done
redock
tetrapeptid
inhibitor
bznlelysargargh
rmsd
valu
greater
extern
valid
done
use
panduratin
competit
inhibitor
dock
bind
site
tetrapeptid
inhibitor
silico
screen
ligand
nci
divers
set
ii
carri
use
dock
paramet
hit
compound
rank
accord
free
energi
bind
bind
analysi
bind
mode
perform
use
discoveri
studio
wwwaccelryscom
express
carri
accord
establish
method
yusof
et
al
minor
modif
accord
publish
articl
plasmid
encod
proteas
sequenc
transform
escherichia
coli
strain
transform
express
plasmid
grown
lb
medium
contain
ampicillin
od
reach
first
cell
incub
rpm
od
one
ml
mm
lb
medium
ad
bacteri
cell
hour
induc
protein
express
express
recombin
protein
induc
addit
iptg
cultur
incub
hour
cell
harvest
centrifug
rpm
sorval
refriger
superspe
centrifug
minut
cell
pellet
thaw
g
resuspend
lysi
buffer
ml
follow
mix
use
vortex
milki
purif
cell
lyse
sonic
conduct
time
puls
duti
cycl
output
control
use
ultrason
cell
disruptor
branson
sonifi
germani
lysat
incub
ice
hour
centrifug
rpm
hour
solubl
nativ
form
filter
batchbound
x
ml
ni
nta
nickelnitrilotriacet
acid
resin
preequilibr
column
buffer
incub
overnight
resin
clean
unbound
fraction
centrifug
resin
bound
protein
collect
load
column
biorad
x
cm
gradient
techniqu
column
wash
extens
x
ml
wash
buffer
elut
ml
elut
buffer
column
monitor
use
biorad
bradford
protein
assay
purifi
protein
analys
sdspage
pool
store
use
dengu
proteas
activ
inhibit
studi
dengu
proteas
activ
assay
develop
previous
describ
slight
modif
briefli
assay
system
compris
mm
trishcl
ph
buffer
bocgrrmca
substrat
proteas
optimum
assay
execut
ascertain
maximum
proteas
activ
constant
concentr
substrat
proteas
concentr
vari
within
amc
produc
measur
fluoresc
intens
excit
nm
emiss
nm
use
elisa
modulu
micropl
reader
compound
also
check
requir
pass
pan
assay
interfer
compound
pain
http
cbligandorgpain
test
inhibit
activ
rang
concentr
result
show
test
compound
except
pass
pain
filter
concentr
proteas
use
initi
incub
compound
minut
rpm
rotat
subsequ
substrat
ad
incub
prolong
minut
fluoresc
intens
nm
measur
amc
byproduct
releas
upon
peptid
substrat
cleavag
proteas
experi
triplic
panduratin
use
posit
control
reaction
carri
use
standard
techniqu
exclus
moistur
except
aqueou
media
progress
reaction
monitor
use
tlc
mm
silica
f
detect
uv
light
iodin
vapor
hnmr
cnmr
spectra
determin
use
bruker
avanc
spectromet
tm
intern
standard
mass
spectra
determin
use
melt
point
obtain
use
stuart
smp
electrotherm
apparatu
uncorrect
anhydr
reaction
carri
overdri
glasswar
nitrogen
atmospher
detail
method
synthesi
compound
structur
well
number
due
nmr
assign
seen
text
obtain
bound
pose
thioguanin
analogu
md
simul
molecular
dock
carri
structur
two
activ
compound
construct
minimis
use
hyperchem
step
steepest
descent
follow
step
conjug
gradient
minimis
structur
subject
molecular
dock
use
model
use
virtual
screen
use
protein
inhibitor
compound
subsequ
prepar
use
autodocktool
polar
hydrogen
kollman
charg
ad
denv
prepar
ligand
nonpolar
hydrogen
atom
merg
gasteig
charg
assign
grid
box
size
grid
space
set
around
catalyt
triad
dimens
respect
centr
set
x
z
use
run
dock
lamarckian
genet
algorithm
ga
search
program
appli
gener
run
conform
one
lowest
free
energi
bind
popul
cluster
select
dock
conform
compound
use
start
structur
subsequ
dynam
studi
interact
analysi
conduct
use
ligplu
vmd
panduratin
use
posit
control
prepar
simul
similar
way
compound
gain
insight
bind
interact
compound
panduratin
molecular
dynam
simul
carri
use
amber
follow
descript
setup
compound
compound
system
prepar
use
leap
program
amber
generalis
forc
file
gaff
assign
three
compound
whilst
amber
system
neutralis
sodium
ion
solvat
use
water
truncat
octahedr
water
box
elimin
steric
clash
system
subject
total
stepwis
minimis
use
steepest
descent
follow
conjug
gradient
solvent
system
first
heat
k
nvt
ensembl
follow
heat
whole
system
k
npt
ensembl
throughout
md
simul
fs
time
step
shake
algorithm
period
boundari
cutoff
appli
analysi
rmsd
gyrat
taken
begin
equilibr
phase
ns
product
phase
simul
ns
total
simul
time
ns
system
analysi
conduct
use
cpptraj
modul
ambertool
visualis
vmd
total
frame
extract
last
nanosecond
ns
simul
trajectori
file
mmpbsa
calcul
perform
frame
use
mmpbsapi
modul
amber
energi
composit
compound
well
panduratin
dissect
accordingli
studi
compound
nci
divers
set
ii
dock
activ
site
pocket
activ
site
made
import
amino
acid
residu
subpocket
pocket
top
hit
compound
investig
interact
activ
site
residu
rank
term
free
energi
bind
bind
kcalmol
kcalmol
see
tabl
identifi
ligand
dock
activ
site
bind
rang
show
interest
interact
essenti
amino
acid
residu
select
bind
rang
adopt
studi
report
shityakov
gibb
free
energi
bind
kcalmol
cluster
activ
predict
highli
correl
experiment
result
r
f
standard
error
estim
pvalu
virtual
screen
studi
limit
decoy
databas
use
valid
dock
protocol
nonbind
molecul
could
select
true
ligand
call
fals
posit
decoy
databas
fals
posit
hit
may
improv
valid
test
gener
true
posit
rate
well
enrich
factor
unfortun
decoy
avail
databas
use
decoy
dud
dudedockingorg
therefor
valid
virtual
screen
reli
intern
control
dock
vitro
assay
hit
identifi
virtual
screen
avail
inhibit
assay
compound
compound
exhibit
signific
inhibit
activ
toward
activ
fig
nci
compound
exhibit
neglig
inhibit
inhibit
toward
proteas
activ
four
nci
compound
percentag
inhibit
greater
select
assay
determin
ic
fig
show
strongest
inhibit
toward
proteas
activ
ic
follow
tabl
panduratin
use
control
experi
previous
panduratin
isol
finger
root
boesenbergia
rotunda
l
demonstr
competit
inhibit
toward
k
thioguaninebas
proteas
inhibitor
demonstr
best
inhibit
toward
proteas
activ
concentr
less
rel
proteas
activ
dramat
decreas
ic
inhibit
probabl
provid
hydrogen
bond
phenyl
ring
compound
form
fig
ic
second
potent
four
nci
compound
activ
might
contribut
hbond
interact
interact
anthracen
ring
interact
fig
b
also
demonstr
signific
inhibit
toward
proteas
ic
dock
pose
show
format
hbond
amino
group
interact
guanin
ring
fig
c
although
ic
approxim
compound
show
nearli
inhibit
proteas
activ
nci
compound
ligand
also
form
well
interact
respect
addit
hbond
interact
amino
group
fig
thioguaninebas
proteas
inhibitor
quest
identifi
suitabl
scaffold
design
potenti
novel
potent
dengu
proteas
inhibitor
took
consider
structur
although
potent
compound
identifi
virtual
screen
structur
contain
thioguanin
tg
scaffold
tg
known
drug
use
compound
treat
leukemia
also
investig
pharmacolog
activ
autoimmun
diseas
transplant
graft
reject
addit
simpl
chemic
structur
also
benefit
feasibl
synthet
step
thu
tg
select
templat
develop
seri
analogu
therefor
order
test
hypothesi
tg
subject
proteas
inhibit
assay
found
molecul
show
inhibit
mm
indic
even
without
modif
structur
scaffold
abl
inhibit
proteas
activ
thu
tg
chosen
lead
structur
design
synthesi
potenti
antidengu
compound
variou
thioguanin
deriv
design
shown
tabl
scaffold
illustr
fig
design
initi
connect
aromat
hydrophil
group
hydrogen
bond
acceptor
hba
amino
group
aromat
hydrophob
group
sulfonyl
r
acyl
group
acetyl
butanoyl
isobutanoyl
pentanoyl
isopentanoyl
hexanoyl
group
place
posit
benzoyl
group
instead
place
replac
aliphat
hydrophob
group
r
cyclopentyl
group
present
yield
compound
imin
deriv
tg
imin
electron
withdraw
natur
albeit
weakli
attach
anoth
ewg
cooh
thioguaninebas
proteas
inhibitor
benzimin
para
posit
r
render
compound
inact
ic
interestingli
attach
electron
donat
group
edg
benzimin
r
show
high
proteas
inhibit
ic
rais
idea
maintain
ewg
group
linker
two
aromat
ring
tg
phenyl
group
modifi
edg
charact
compound
design
sulfonyl
ewg
ch
och
edg
benzenesulfonyl
r
compound
demonstr
lower
activ
ic
respect
group
attach
r
also
place
r
synthesi
chang
activ
insignific
place
r
acetyl
extend
alkyl
chain
gener
result
mark
reduct
proteas
inhibit
except
note
show
ic
place
simpl
aromat
hydrophob
group
benzoyl
seen
increas
activ
explor
placement
r
aliphat
hydrophob
group
also
produc
compound
improv
proteas
inhibit
activ
point
decid
synthes
six
compound
expect
higher
activ
thioguaninebas
proteas
inhibitor
inspir
compound
amid
group
promis
inhibitori
activ
six
compound
see
tabl
amid
group
divers
alkyl
chain
design
natur
substrat
proteas
peptid
made
sens
incorpor
amid
group
inhibitor
structur
order
mimic
peptid
charact
high
activ
toward
ic
respect
could
due
mimic
peptid
charact
compound
pentanamid
chain
r
r
possess
highest
activ
proteas
howev
attach
benzyl
group
r
dramat
decreas
activ
interestingli
attach
benzyl
group
r
significantli
increas
activ
compound
amid
group
extend
shorter
alkyl
chain
show
moder
activ
ic
respect
confirm
essenti
amid
group
compound
amid
group
r
omit
r
replac
methylnaphthalen
whilst
r
isopropyl
chain
predict
activ
significantli
decreas
ic
activitydos
curv
compound
present
fig
dock
result
sever
interact
identifi
interact
residu
indic
potenti
hydrogen
bond
interact
number
bracket
indic
thioguaninebas
proteas
inhibitor
number
wichapong
model
bind
stabil
contribut
hydrophob
interact
surround
entir
bind
site
free
energi
kcalmol
fig
addit
demonstr
bind
affin
kcalmol
hydrogen
bond
also
observ
substanti
stabil
conform
chang
md
simul
carri
understand
dynam
featur
two
best
compound
respect
time
nanosecond
scale
overal
backbon
rmsd
valu
apo
throughout
ns
simul
time
reflect
stabil
system
adopt
higher
rmsd
rang
ns
simul
time
howev
stabilis
ns
simul
time
fig
gyrat
valu
indic
compact
protein
turn
reflect
directli
fold
unfold
protein
unfold
protein
would
affect
kinet
protein
activ
gyrat
four
system
apoenzym
panduratin
fluctuat
less
unfold
observ
low
fluctuat
gyrat
proteinligand
interact
gener
stabilis
variou
type
weak
interact
hydrogen
bond
interact
potenti
one
import
interact
hydrogen
thioguaninebas
proteas
inhibitor
bond
format
observ
sever
import
interact
residu
system
tabl
number
parenthesi
accord
wichapong
model
play
import
role
form
hydrogen
bond
occupi
simul
time
also
found
form
hydrogen
bond
nitrogen
group
total
occup
simul
time
interest
note
import
proteas
activ
also
demonstr
weak
hydrogen
bond
format
occup
respect
thu
postul
hydrogen
network
togeth
hydrophob
cluster
contribut
bind
affin
number
hydrogen
bond
format
observ
lesser
compar
form
hydrogen
bond
nitrogen
group
occup
total
simul
time
two
hydrogen
bond
nitrogen
oxygen
group
occup
weak
hydrogen
bond
observ
interact
residu
less
occup
thioguaninebas
proteas
inhibitor
thioguaninebas
proteas
inhibitor
case
panduratin
weak
hydrogen
bond
less
occup
throughout
found
residu
format
hydrogen
bond
significantli
weaker
compar
interact
decomposit
energi
interact
panduratin
calcul
use
mmpbsa
total
snapshot
extract
everi
ps
interv
last
nanosecond
absolut
bind
free
energi
tabl
panduratin
kcalmol
respect
nonpolar
interact
bind
site
residu
well
aliphat
chain
pentanoyl
provid
major
contribut
bind
energi
bind
panduratin
less
favour
compar
similarli
major
contribut
panduratin
bind
mainli
nonpolar
interact
infer
fact
weak
hydrogen
bond
found
panduratin
low
occup
reflect
bind
panduratin
stabilis
mainli
van
der
waal
hydrophob
interact
bind
free
energi
estim
mmpbsa
calcul
indic
better
bind
compar
ic
better
ident
pentanoyl
r
group
two
aromat
benzyl
group
r
r
instead
carbonyl
chain
hydrogen
r
r
respect
higher
van
der
waal
interact
observ
mmpbsa
calcul
due
presenc
two
benzyl
group
r
r
howev
interact
might
overestim
use
mmpbsa
approach
thioguanin
identifi
potenti
scaffold
inhibitor
base
virtual
screen
vitro
assay
molecular
model
thioguanin
scaffold
compos
pyramidin
imidazol
ring
attach
amin
thiol
group
may
contribut
compound
activ
far
awar
report
pyrimidin
inhibit
howev
benzylthio
report
demonstr
activ
like
proteas
addit
pyrimidin
also
shown
activ
stop
growth
reli
capabl
pyrimidin
inhibit
dihydroorot
dehydrogenas
dhodh
enzym
requir
viral
pyrimidin
biosynthesi
imidazol
also
investig
dengu
viru
howev
exact
molecular
mechan
protein
target
still
unknown
scaffold
report
noncompetit
inhibit
ubiquitin
specif
proteas
variou
cancer
background
postul
thioguanin
deriv
might
potenti
good
inhibitor
thioguaninebas
proteas
inhibitor
two
activ
compound
amid
function
group
instead
amino
group
amid
part
peptid
recognis
key
point
proteas
substrat
dock
studi
amid
group
mark
hbd
namid
interact
ophenol
via
hbond
previous
amid
arylcyanoacrylamid
aminobenzamid
incorpor
design
denv
inhibitor
alkyl
chain
phenylbenzyl
group
demonstr
hydrophob
featur
agreeabl
dock
result
show
group
bound
hydrophob
pocket
surround
also
correl
decomposit
energi
comput
mmpbsa
highlight
major
contribut
interact
nonpolar
interact
interest
note
bind
orient
md
simul
compound
differ
despit
share
similar
thioguanin
fig
thioguanin
moieti
face
toward
respect
compound
acyl
group
r
provid
addit
electron
lone
pair
enabl
format
hydrogen
bond
strengthen
bind
toward
reflect
clearli
hydrogen
bond
analysi
form
hydrogen
bond
compar
regardless
slightli
lower
absolut
bind
energi
mmpbsa
predict
bind
interact
analysi
agre
well
experiment
result
thioguaninebas
proteas
inhibitor
absolut
free
energi
bind
two
activ
compound
also
neg
panduratin
support
vitro
result
compound
better
ic
valu
respect
panduratin
present
comput
design
potenti
inhibitor
virtual
screen
nation
cancer
institut
databas
four
compound
includ
observ
moder
inhibit
activ
proteas
thioguanin
scaffold
structur
prompt
us
consid
scaffold
design
new
thioguanin
deriv
potenti
inhibitor
fifteen
compound
synthesis
bioactiv
dengu
proteas
show
variat
inhibit
activ
inact
moder
activ
ic
base
inform
design
six
new
compound
conduct
concentr
attach
amid
group
compound
show
inhibit
activ
dengu
proteas
compound
potent
ic
result
agre
well
mm
pbsa
calcul
show
interact
mainli
contribut
polar
nonpolar
interact
hydrogen
bond
analysi
demonstr
import
amino
acid
residu
occup
support
experiment
result
show
could
develop
inhibitor
hope
result
obtain
studi
could
use
design
activ
compound
potenti
dengu
proteas
inhibitor
